BIOSANTE PHARMACEUTICALS INC·4

Jan 27, 4:29 PM ET

SIMES STEPHEN M 4

4 · BIOSANTE PHARMACEUTICALS INC · Filed Jan 27, 2012

Insider Transaction Report

Form 4
Period: 2012-01-25
SIMES STEPHEN M
DirectorV Chair, Pres. and CEO
Transactions
  • Award

    Employee Stock Option (right to buy)

    2012-01-25+800,000800,000 total
    Exercise: $0.68Exp: 2022-01-24Common Stock (800,000 underlying)
Holdings
  • Common Stock

    (indirect: By Children)
    100
  • Common Stock

    (indirect: By Trust)
    202,167
Footnotes (1)
  • [F1]This option vests with respect to 200,000 shares on each of January 25, 2013, January 25, 2014, January 25, 2015 and January 25, 2016.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT